Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of diabetic nephropathy.

× No keyword cloud information.

68 in total

1. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors:
Journal: Lancet Date: 2000-01-22 Impact factor: 79.321

2. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors:
Journal: Lancet Date: 1998-01-24 Impact factor: 79.321

3. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.

Authors: H Yokoyama; O Tomonaga; M Hirayama; A Ishii; M Takeda; T Babazono; U Ujihara; C Takahashi; Y Omori
Journal: Diabetologia Date: 1997-04 Impact factor: 10.122

4. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.

Authors: P Rossing; E Hommel; U M Smidt; H H Parving
Journal: Diabetes Date: 1993-05 Impact factor: 9.461

5. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.

Authors: H Yoshida; S Kuriyama; Y Atsumi; H Tomonari; T Mitarai; A Hamaguchi; H Kubo; Y Kawaguchi; V Kon; K Matsuoka; I Ichikawa; O Sakai
Journal: Kidney Int Date: 1996-08 Impact factor: 10.612

6. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

Authors: M A Pfeffer; F M Sacks; L A Moyé; L Brown; J L Rouleau; L H Hartley; J Rouleau; R Grimm; F Sestier; W Wickemeyer
Journal: Am J Cardiol Date: 1995-09-28 Impact factor: 2.778

7. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.

Authors: P Koskinen; M Mänttäri; V Manninen; J K Huttunen; O P Heinonen; M H Frick
Journal: Diabetes Care Date: 1992-07 Impact factor: 19.112

8. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors: C E Mogensen
Journal: Br Med J (Clin Res Ed) Date: 1982-09-11

9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

10. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

Authors: R D Abbott; R P Donahue; W B Kannel; P W Wilson
Journal: JAMA Date: 1988-12-16 Impact factor: 56.272

4 in total

1. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.

Authors: Hamad Ali; Mohamed Abu-Farha; Maha M Hammad; Sriraman Devarajan; Yousif Bahbahani; Irina Al-Khairi; Preethi Cherian; Zahra Alsairafi; Vidya Vijayan; Fahd Al-Mulla; Abdulnabi Al Attar; Jehad Abubaker
Journal: Front Endocrinol (Lausanne) Date: 2022-05-31 Impact factor: 6.055

Management of diabetic nephropathy.